PA8441701A1 - Sales dimesilato de los ligandos del neuropeptido y - Google Patents

Sales dimesilato de los ligandos del neuropeptido y

Info

Publication number
PA8441701A1
PA8441701A1 PA19978441701A PA8441701A PA8441701A1 PA 8441701 A1 PA8441701 A1 PA 8441701A1 PA 19978441701 A PA19978441701 A PA 19978441701A PA 8441701 A PA8441701 A PA 8441701A PA 8441701 A1 PA8441701 A1 PA 8441701A1
Authority
PA
Panama
Prior art keywords
dimesylate
salts
neuropeptide ligands
neuropeptide
ligands
Prior art date
Application number
PA19978441701A
Other languages
English (en)
Inventor
Douglas Allen
Alireza Kord
Laurie Whipple
Lyle Robinson Brostrom
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PA8441701A1 publication Critical patent/PA8441701A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Abstract

LA SAL DIMESILATO DEL CIS -1-(3-ETOXIFENIL)-1-(4-FENILPIPERAZIN-1-I1)-4- METILCICLOHEXANO TIENE PROPIEDADES EXCELENTES Y ES UTIL PARA EL TRATAMIENTO DE TRASTORNOS FISIOLOGICOS ASOCIADOS CON UN EXCESO DE NEUROPEPTIDO Y.
PA19978441701A 1996-11-26 1997-11-18 Sales dimesilato de los ligandos del neuropeptido y PA8441701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
PA8441701A1 true PA8441701A1 (es) 2000-05-24

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19978441701A PA8441701A1 (es) 1996-11-26 1997-11-18 Sales dimesilato de los ligandos del neuropeptido y

Country Status (23)

Country Link
US (1) US5914329A (es)
EP (1) EP0944611B1 (es)
JP (1) JP3120861B2 (es)
AP (1) AP9701148A0 (es)
AR (1) AR010304A1 (es)
AT (1) ATE257472T1 (es)
AU (1) AU4792497A (es)
BR (1) BR9713538A (es)
CA (1) CA2272927C (es)
DE (1) DE69727155T2 (es)
DK (1) DK0944611T3 (es)
ES (1) ES2213207T3 (es)
GT (1) GT199700123A (es)
HN (1) HN1997000154A (es)
HR (1) HRP970640A2 (es)
ID (1) ID18964A (es)
MA (1) MA26450A1 (es)
PA (1) PA8441701A1 (es)
PE (1) PE17099A1 (es)
PT (1) PT944611E (es)
TN (1) TNSN97191A1 (es)
WO (1) WO1998023603A1 (es)
ZA (1) ZA9710587B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053864A1 (en) * 2000-01-20 2004-03-18 Gerard Karsenty Methods and compositions for control of bone formation via modulation of neuropeptide y activity
WO2003049673A2 (en) 2001-12-05 2003-06-19 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of sympathetic tone
DK1470228T3 (da) 2002-01-09 2006-07-31 Arexis Ab Detektion af mutationer
BRPI0514386B8 (pt) * 2004-11-23 2021-05-25 Dong Wha Pharmaceutical Ind Co Ltd bis (metanossulfonato) de n-hidróxi-4-{5-[4-(5-isopropil-2-metil-1,3-triazol-4-il)fenóxi]pentóxi}benzamidina, método para preparar os mesmos, suas composições farmacêuticas e formulações orais
WO2006108218A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970707101A (ko) * 1994-11-07 1997-12-01 스피겔 알렌 제이 치환된 벤질아민 유도체; 신규한 부류의 신경펩타이드 y1 특이적 리간드(certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands)

Also Published As

Publication number Publication date
DE69727155T2 (de) 2004-07-08
ID18964A (id) 1998-05-28
MA26450A1 (fr) 2004-12-20
PE17099A1 (es) 1999-02-19
DE69727155D1 (de) 2004-02-12
TNSN97191A1 (fr) 2005-03-15
EP0944611B1 (en) 2004-01-07
AR010304A1 (es) 2000-06-07
ZA9710587B (en) 1999-05-25
GT199700123A (es) 1999-05-19
EP0944611A1 (en) 1999-09-29
CA2272927C (en) 2003-02-04
AP9701148A0 (en) 1998-01-31
BR9713538A (es) 2000-03-21
US5914329A (en) 1999-06-22
AU4792497A (en) 1998-06-22
PT944611E (pt) 2004-04-30
HN1997000154A (es) 1999-02-09
ATE257472T1 (de) 2004-01-15
WO1998023603A1 (en) 1998-06-04
HRP970640A2 (en) 1998-10-31
DK0944611T3 (da) 2004-04-13
ES2213207T3 (es) 2004-08-16
JP2000505110A (ja) 2000-04-25
JP3120861B2 (ja) 2000-12-25
CA2272927A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
EA199800667A1 (ru) Новые фенантридины
ATE234092T1 (de) 2-alkylpyrrolidine
ATE422329T1 (de) Verarbeitung von elektrokardiogrammsignälen mit überlappenden komplexen
FI930772A (fi) Hydroxiureaderivat som saenker glugosnivao i blodet
ES2195970T3 (es) L-ribavirina y usos de la misma.
RS51013B (sr) Indolinon supstituisan na poziciji 6, njegovo dobijanje i njegova upotreba kao leka
DK0767669T3 (da) Nyt farmaceutisk præparat til smertebehandling
RS49795B (sr) Sredstva sa antidepresivnim dejstvom
EA199900912A1 (ru) Фармацевтические средства
ATE197229T1 (de) Zahnbürste
PA8441701A1 (es) Sales dimesilato de los ligandos del neuropeptido y
ATE203519T1 (de) Chinolinderivate als antimalariamittel
ATE210447T1 (de) Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen
DE69718208D1 (de) Rettungsvorrichtung
LV11940A (lv) Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas
SE9401174D0 (sv) New combination
ECSP972321A (es) Sales dimesilato de los ligandos del neuropeptido y antecedentes de la invencion
FI970330A (fi) Imidatsopyridiini-atsolidinonit
ES269428Y (es) Disposicion de napa.
ES2060405T3 (es) Derivado de la melatonina que tiene actividad terapeutica en dermatologia.
ATE373475T1 (de) Carbamate von 2-heterozyklischen 1,2-ethandiolen
ATE251909T1 (de) Verwendung von mitteln die den wachstumsfaktor beeinflussen
ECSP961701A (es) Metodos para mejorar la salud de los bananos
UY24121A1 (es) Nuevas sulfonamidas
DE20002456U1 (de) Schutzvorrichtung für Untergestelle von Festzeltgarnituren